Sopharma Trading AD (BUL:SFT)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 3.680
-0.120 (-3.16%)
At close: Feb 4, 2026
Sopharma Trading AD Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,225 | 1,942 | 1,673 | 1,479 | 1,336 | 1,156 |
Other Revenue | 12.01 | 9.41 | 5.06 | 4.26 | - | - |
| 2,237 | 1,951 | 1,678 | 1,483 | 1,336 | 1,156 | |
Revenue Growth (YoY) | 20.47% | 16.25% | 13.20% | 11.00% | 15.53% | 22.25% |
Cost of Revenue | 1,928 | 1,701 | 1,482 | 1,311 | 1,193 | 1,052 |
Gross Profit | 309.04 | 250.08 | 196.01 | 172.13 | 142.34 | 104.06 |
Selling, General & Admin | 177.32 | 149.07 | 115.57 | 100.73 | 97.75 | 71.81 |
Other Operating Expenses | 3.53 | 4.03 | 3.61 | 1.47 | -0.29 | -5.3 |
Operating Expenses | 224.39 | 190.02 | 151.29 | 132.26 | 126.29 | 86.67 |
Operating Income | 84.65 | 60.05 | 44.71 | 39.87 | 16.05 | 17.39 |
Interest Expense | -11.75 | -9.76 | -8.42 | -5.18 | -5.36 | -4.46 |
Interest & Investment Income | 1.11 | 1.1 | 0.47 | 0.71 | 2.11 | 1.67 |
Earnings From Equity Investments | -0.04 | -0.01 | - | - | - | - |
Currency Exchange Gain (Loss) | -2.38 | -4.47 | -0.13 | -0.11 | -0.16 | -0.19 |
Other Non Operating Income (Expenses) | -0.73 | -0.71 | -2.63 | -1.75 | -0.97 | -0.84 |
EBT Excluding Unusual Items | 70.86 | 46.22 | 34 | 33.55 | 11.66 | 13.57 |
Merger & Restructuring Charges | - | -0.12 | - | - | - | - |
Impairment of Goodwill | - | - | - | -13.33 | - | - |
Gain (Loss) on Sale of Assets | 0.46 | 0.57 | 0.21 | 0.46 | 0.3 | 0.25 |
Asset Writedown | - | - | - | -8.28 | -2.64 | - |
Other Unusual Items | 0.34 | 0.34 | - | - | 0.12 | 0.1 |
Pretax Income | 71.66 | 47.01 | 34.21 | 12.39 | 9.44 | 13.92 |
Income Tax Expense | 9.23 | 7.23 | 5 | 3.31 | 1.39 | 2.45 |
Earnings From Continuing Operations | 62.43 | 39.78 | 29.21 | 9.08 | 8.05 | 11.48 |
Minority Interest in Earnings | 0.05 | 0.49 | - | - | - | - |
Net Income | 62.48 | 40.27 | 29.21 | 9.08 | 8.05 | 11.48 |
Net Income to Common | 62.48 | 40.27 | 29.21 | 9.08 | 8.05 | 11.48 |
Net Income Growth | 67.39% | 37.87% | 221.67% | 12.80% | -29.85% | 28.60% |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Change (YoY) | -0.66% | -0.13% | - | - | - | - |
EPS (Basic) | 1.83 | 1.18 | 0.85 | 0.26 | 0.23 | 0.33 |
EPS (Diluted) | 1.83 | 1.18 | 0.85 | 0.26 | 0.23 | 0.33 |
EPS Growth | 68.51% | 38.05% | 221.67% | 12.80% | -29.85% | 28.60% |
Free Cash Flow | -16.94 | 54.64 | 37.63 | 12.84 | -180.39 | -225.62 |
Free Cash Flow Per Share | -0.50 | 1.60 | 1.10 | 0.38 | -5.26 | -6.58 |
Gross Margin | 13.82% | 12.82% | 11.68% | 11.61% | 10.66% | 9.00% |
Operating Margin | 3.78% | 3.08% | 2.66% | 2.69% | 1.20% | 1.50% |
Profit Margin | 2.79% | 2.06% | 1.74% | 0.61% | 0.60% | 0.99% |
Free Cash Flow Margin | -0.76% | 2.80% | 2.24% | 0.87% | -13.50% | -19.51% |
EBITDA | 104 | 93.21 | 73.53 | 67.21 | 28.08 | 26.02 |
EBITDA Margin | 4.65% | 4.78% | 4.38% | 4.53% | 2.10% | 2.25% |
D&A For EBITDA | 19.35 | 33.16 | 28.82 | 27.34 | 12.03 | 8.63 |
EBIT | 84.65 | 60.05 | 44.71 | 39.87 | 16.05 | 17.39 |
EBIT Margin | 3.78% | 3.08% | 2.66% | 2.69% | 1.20% | 1.50% |
Effective Tax Rate | 12.88% | 15.37% | 14.62% | 26.73% | 14.70% | 17.57% |
Advertising Expenses | - | 11.21 | 6.55 | 4.14 | 3.46 | 3.12 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.